VIRX
Viracta Therapeutics Inc
Price:  
0.08 
USD
Volume:  
9,368,752.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VIRX Stock Forecast & Price Target

VIRX Stock Price Forecast

The average stock forecast for Viracta Therapeutics Inc (VIRX) in the next 12 months is 3.06 USD. This price target corresponds to an upside of 3,833.16%. The range of stock forecasts for VIRX is 3.03 - 3.15 USD. Based on the ratings of 6 analysts, the consensus recommendation for VIRX is HOLD.
Target Low Average Median High
Price (USD) 3.03 3.06 3.06 3.15
Upside 3,794.60% 3,833.16% 3,833.16% 3,948.84%

Recommendation Trends

The latest consensus rating for VIRX is "HOLD". This is the average recommendation of 6 analysts: 2 strong sell, 1 sell, 3 hold, 0 buy, 0 strong buy. In the previous period, 6 analysts also majorly recommmended "HOLD" for VIRX.

VIRX Financial Stock Forecast

Revenue This Year
-M
from -M
Revenue Next Year
from -M
EPS This Year
-0.81
-37.11%
from -1.28
EPS Next Year
from -0.81